Question 1

What is BIO?

Accepted Answer

BIO is Bio Protocol’s native utility and governance token. Bio Protocol serves the decentralized science ecosystem, and BIO is designed to connect community participation, project participation, liquidity, and protocol governance; it is not equity in a company or an inherent claim on its profits. BIO is the native token at the protocol layer; ecosystem projects may have their own tokens, governance arrangements, and risks, and the two should not be conflated.

Question 2

What can BIO be used for?

Accepted Answer

Official documentation lists BIO uses including staking, participating in new project offerings, providing liquidity for ecosystem project tokens, and accessing ecosystem services such as BioAgents. Whether each use is available, its applicable conditions, and required actions are determined by the relevant product or governance rules. These uses are mechanisms for protocol participation and service access; they do not mean that holding BIO automatically grants every service, a project share, or fixed returns.

Question 3

After staking BIO, what are the respective roles of veBIO and BioXP?

Accepted Answer

Staking BIO provides veBIO; veBIO is a locked credential for protocol-governance voting, enabling participants to vote on matters related to protocol upgrades and treasury assets. Staking can also provide BioXP, which officials describe as being used to participate in new project offerings. veBIO represents governance voting rights, while BioXP represents the mechanism for participating in project offerings. Both are triggered by staking, but voting rights, eligibility for project participation, and any investment returns should not be conflated.

Question 4

What specifically do veBIO governance rights cover?

Accepted Answer

veBIO is used for Bio Protocol governance: holders use this locked credential to participate in decisions related to protocol upgrades and treasury assets. Governance affects protocol rules or treasury-related matters; it does not mean directly making operating decisions for every scientific project in the ecosystem. Being able to vote does not mean a particular proposal will necessarily pass, nor does it mean that a governance decision automatically changes BIO’s supply, price, or project-token performance; these outcomes depend on the specific proposal and its subsequent implementation.

Question 5

How does BioXP relate to new project offerings?

Accepted Answer

BioXP is the point described in official documentation as being obtained through BIO staking and used to participate in new project offerings. Its function is to connect staking activity with an entry point for project participation, rather than to be another governance token understood as equivalent to BIO. Eligibility to participate in a project offering still depends on that offering’s specific rules and applicable conditions. Receiving BioXP should not be understood as already receiving project tokens or as guaranteeing an allocation.

Question 6

How does BIO relate to liquidity for ecosystem project tokens?

Accepted Answer

BIO can serve as the primary paired asset in liquidity pools for ecosystem project tokens. A paired asset enables traders to exchange project tokens and BIO in a pool, thereby creating on-chain liquidity for project tokens. Liquidity providers must face price changes in both assets. When the relative price in the pool changes, the composition of the position changes, which may result in impermanent loss. Providing liquidity is not simply holding BIO and does not guarantee fixed returns.

Question 7

Is BIO’s supply fixed?

Accepted Answer

BIO has an initial supply of 3.32 billion tokens, but it is not a capped supply. Official documentation explains that if additional BIO is needed in the future for protocol or network growth, a new contract replacing the current token must be deployed. This means that “initial supply” is not a permanent maximum supply. However, additional supply is also not described as unlimited automatic minting by the existing contract. Whether expansion occurs, when it occurs, and its amount should follow the formal contract and governance or project documentation in effect at that time.

Question 8

How is BIO’s initial allocation arranged?

Accepted Answer

In the initial allocation, the community receives 56%, including the community auction, airdrop, ecosystem incentives, and the Molecule ecosystem fund; the remainder is allocated to early supporters, early contributors, advisors, and Molecule. This structure describes initial allocation categories, not a snapshot of the currently freely tradable balance of each category. The use of ecosystem incentives requires a governance vote. Therefore, “allocated to the community” does not mean that all shares were distributed, circulating, or claimable by any individual at the outset.

Question 9

What is the difference between the initial allocation, vesting, and circulating supply?

Accepted Answer

Some initial BIO allocations are released according to vesting schedules. Vesting is an arrangement under which entitlement to allocated tokens gradually becomes obtainable over time or upon conditions being met; it is a different measure from total token supply, on-chain balances, and real-time circulating supply. Therefore, initial allocation percentages alone cannot be used to calculate the amount tradable on a given day. To assess actual circulation or unlocking, the formal vesting arrangements for the applicable category and the then-current on-chain or project disclosures must be consulted.

Question 10

How should the connection between ecosystem use and BIO’s value be understood?

Accepted Answer

BIO’s economic connection comes from its use for staking, project participation, liquidity, and service access. For example, when participants stake to obtain veBIO or BioXP, or pair BIO in relevant liquidity pools, corresponding use cases arise. However, product adoption, the number of projects, or trading volume do not automatically equate to purchase demand for BIO or a price increase. Actual effects also depend on whether specific rules require holding or using BIO, tradable supply, participants’ choices, and market conditions.

Question 11

What is the relationship between BIO and ecosystem project tokens?

Accepted Answer

BIO is the protocol’s native token, while ecosystem project tokens correspond to specific projects. BIO can be used as a paired asset in project-token liquidity pools and can connect governance and participation in project offerings through staking mechanisms, but this does not automatically convert BIO into an entitlement to every project token. When evaluating an ecosystem project, its token issuance, rights, liquidity, and risks must be confirmed separately. BIO’s uses cannot substitute for an assessment of the project token itself.

Question 12

Where can official information about BIO be obtained?

Accepted Answer

For information on BIO’s uses, governance staking, and token supply, Bio Protocol’s official BIO Token and Basic Token Information pages should be consulted first. They describe, respectively, its uses and its initial supply, allocation, and partial vesting information. Available token networks, contract addresses, real-time circulating supply, and specific offering rules may change with products or deployments; each item should be checked against the latest official page for the relevant network and product.

Bio Protocol (BIO) Price